{
    "2020-08-19": [
        [
            {
                "time": "2020-08-19",
                "original_text": "上调评级至买入策略选股（8月19日）",
                "features": {
                    "keywords": [
                        "评级",
                        "买入",
                        "策略",
                        "选股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-19",
                "original_text": "金域医学主业毛利率升至45% 核酸检测量超千万带动收入增长36%",
                "features": {
                    "keywords": [
                        "金域医学",
                        "毛利率",
                        "核酸检测",
                        "收入增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-19",
                "original_text": "金域医学(603882)：业绩超市场预期 股权激励再添信心",
                "features": {
                    "keywords": [
                        "金域医学",
                        "业绩",
                        "市场预期",
                        "股权激励"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-19",
                "original_text": "金域医学(603882)：ICL蓝海行业龙头 上半年业绩超预期",
                "features": {
                    "keywords": [
                        "金域医学",
                        "ICL",
                        "蓝海行业",
                        "龙头",
                        "业绩"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-19",
                "original_text": "医药生物行业投资周报：保持定力紧抓优势赛道龙头 疫情股侧重长期影响和疫苗临床进展",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资",
                        "疫情",
                        "疫苗",
                        "临床进展"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-19",
                "original_text": "金域医学VS迪安诊断，加码新冠检测争夺医检市场“王位”",
                "features": {
                    "keywords": [
                        "金域医学",
                        "迪安诊断",
                        "新冠检测",
                        "医检市场"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-08-19",
                "original_text": "金域医学(603882)：2020半年度业绩超市场预期 新冠检测贡献明显业绩",
                "features": {
                    "keywords": [
                        "金域医学",
                        "2020半年度",
                        "业绩",
                        "新冠检测"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-19",
                "original_text": "医药行业周报：如何看待近期医药的回调？",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "回调"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-08-19",
                "original_text": "31公司获得增持评级 - 更新中",
                "features": {
                    "keywords": [
                        "公司",
                        "增持评级"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}